Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lectin mannose-binding 2-like protein (LMAN2L) is a member of the L-type lectin family of type 1 membrane proteins and is primarily localized in the endoplasmic reticulum (ER) of mammalian cells. Unlike other L-type lectins that cycle between the ER and Golgi, LMAN2L is a non-cycling resident protein of the ER, functioning as a cargo receptor for glycoproteins destined for secretion or membrane localization. It helps regulate the export of properly folded glycoproteins to the Golgi apparatus and facilitates sorting of misfolded glycoproteins for degradation via the ubiquitin-proteasome pathway. Its gene is associated with certain intellectual developmental disorders but is not known to be a direct target of approved pharmacological agents or major therapeutic programs.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lectin mannose-binding 2-like protein (LMAN2L).